AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
35 hedge funds and large institutions have $15.6M invested in AVEO Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
77% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 30
Holders
35
Holding in Top 10
–
Calls
$4.06M
Puts
$3.54M
Top Buyers
| 1 | +$406K | |
| 2 | +$142K | |
| 3 | +$35K | |
| 4 |
WA
WealthTrust Axiom
Wayne,
Pennsylvania
|
+$28.7K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.5K |
Top Sellers
| 1 | -$212K | |
| 2 | -$61K | |
| 3 | -$50K | |
| 4 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$42K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$35.1K |